查找地点
有关时间、上门服务和预约查找地点
有关时间、上门服务和预约
80503; 85240(x3); 85245(x3); 85246(x3) |
80503; 85240(x3); 85245(x3); 85246(x3)80503; 85240(x3); 85245(x3); 85246(x3) |
3 - 5 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
|
3 - 5 days |
Citrated plasma, frozen
2 mL per timepoint
1.5 mL per timepoint (Note: This volume does not allow for repeat testing.)
Blue-top (sodium citrate) tube
Centrifuge at 2500 xg for 10 minutes. Separate plasma from cells within 3 hours of venipuncture. Centrifuge plasma a second time and place in plastic transport tubes. Freeze within 4 hours and keep frozen until testing is performed.
Plasma, frozen
Temperature | Period |
---|---|
Frozen | 6 months |
Freeze/thaw cycles | Stable x1 |
This profile is designed to assess the response of DDAVP treatment in patients presenting with Von Willebrand Disease by measuring VWF and factor VIII levels pre-treatment (baseline) and at two time-points (1 hr and 4 hr) post-treatment. Post-treatment VWF levels are evaluated against baseline results to determine whether the response is adequate and sustained. Results should be correlated with clinical symptoms and family history.
Clotting, platelet agglutination, latex immunoagglutination
This profile contains testing for FVIII Activity, VWF Activity and VWF Antigen at three timepoints: baseline, 1 hour and 4 hours post-treatment with DDAVP. It also contains a pathologist Interpretation of all test results.
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
504836 | DDAVP Challenge for VWD | 500684 | Pathologist Interpretation | 21026-0 | ||
504836 | DDAVP Challenge for VWD | 504841 | Factor VIII Act, Timepoint 1 | % | 3209-4 | |
504836 | DDAVP Challenge for VWD | 504831 | vWF Activity, Timepoint 1 | % | 6014-5 | |
504836 | DDAVP Challenge for VWD | 504827 | vWF Antigen, Timepoint 1 | % | 27816-8 | |
504836 | DDAVP Challenge for VWD | 504842 | Factor VIII Act, Timepoint 2 | % | 3209-4 | |
504836 | DDAVP Challenge for VWD | 504832 | vWF Activity, Timepoint 2 | % | 6014-5 | |
504836 | DDAVP Challenge for VWD | 504828 | vWF Antigen, Timepoint 2 | % | 27816-8 | |
504836 | DDAVP Challenge for VWD | 504843 | Factor VIII Act, Timepoint 3 | % | 3209-4 | |
504836 | DDAVP Challenge for VWD | 504833 | vWF Activity, Timepoint 3 | % | 6014-5 | |
504836 | DDAVP Challenge for VWD | 504829 | vWF Antigen, Timepoint 3 | % | 27816-8 |
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf